Recent

% | $
Quotes you view appear here for quick access.

Aeterna Zentaris Inc. Message Board

  • biotechnewsstockreview biotechnewsstockreview Jan 21, 2013 9:41 PM Flag

    Aeterna Zentaris (AEZS) Price Target $7 By 4th Quarter Following Agreement With FDA On Special Protocol Assessment (SPA) Forecasts Biotech News Stock Review

    Aeterna Zentaris (AEZS) Price Target $7 By 4th Quarter Following Agreement With FDA On Special Protocol Assessment (SPA) Forecasts Biotech News Stock Review

 
AEZS
0.272-0.003(-1.09%)Jul 2 4:00 PMEDT